COVID-19 Updates
From the Journals
New ivermectin, HCQ scripts highest in GOP-dominated counties
Rates of new hydroxychloroquine (HCQ) prescriptions particularly increased in highly Republican counties after the Food and Drug Administration...
Conference Coverage
Long COVID is real and consists of these conditions – or does it?
“I think this is at least helpful in telling us what disease states are different pre- and post COVID, and what sorts of diagnoses clinicians...
Latest News
About 73% of U.S. estimated to be immune to Omicron variant
Nationwide, about 80 million Americans are still vulnerable. “The 26% who could still get Omicron right now have to be very careful.”
From the Journals
Thirty-seven percent of COVID-19 patients lose sense of taste, study says
“Reports of taste loss are in fact genuine and distinguishable from smell loss.”
Conference Coverage
Stroke risk is highest right after COVID infection
The study highlights the impact COVID-19 has on the cardiovascular system.
Latest News
Medical boards pressured to let it slide when doctors spread COVID misinformation
Even defining misinformation has been difficult. And during the pandemic, resistance from some state legislatures is complicating the effort.
Latest News
New study shows natural immunity to COVID has enduring strength
“The study involved only the early COVID strains – it has no information on either the Delta or Omicron variants.”
Latest News
Long COVID symptoms linked to effects on vagus nerve
Several long COVID symptoms could be linked to the effects of the coronavirus on a vital central nerve, according to new research being released...
Commentary
Organ transplantation: Unvaccinated need not apply
Pandemic-era physicians must now consider whether a politically motivated choice to decline COVID-19 vaccination should negatively affect the...
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
News
FDA delays action on Pfizer vaccine for kids under 5
“At this time it makes sense for us to wait until we have the data of the evaluation of a third dose before taking action.”